SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 487.36 |
| Enterprise Value ($M) | 899.27 |
| Book Value ($M) | -154.17 |
| Book Value / Share | -2.66 |
| Price / Book | -3.16 |
| NCAV ($M) | -302.59 |
| NCAV / Share | -5.22 |
| Price / NCAV | -1.61 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.48 |
| Return on Assets (ROA) | -0.36 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.96 |
| Current Ratio | 2.96 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 164.92 |
| Assets | 313.33 |
| Liabilities | 467.51 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ingalls & Snyder Llc | 7.20 | -6.09 | |
| 13G/A | Demopulos Gregory A MD | 8.80 | 2.74 | |
| 13G | Vanguard Group Inc | 5.04 | 12.36 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 143,604 | 458,635 | 31.31 | |
| 86,413 | 505,150 | 17.11 | |
| 50,357 | 299,378 | 16.82 | |
| 77,284 | 437,289 | 17.67 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| OCS – Oculis Holding AG | OCUL – Ocular Therapeutix, Inc. |
| OKUR – OnKure Therapeutics, Inc. | PAHC – Phibro Animal Health Corporation |
| PTGX – Protagonist Therapeutics, Inc. |